Astragaloside IV mitigates cerebral ischaemia-reperfusion injury via inhibition of P62/Keap1/Nrf2 pathway-mediated ferroptosis
Open Access
- 7 February 2023
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 944, 175516
Abstract
No abstract availableKeywords
Funding Information
- Health Commission of Hunan Province (B202303079716)
- National Natural Science Foundation of China (81503385)
- Natural Science Foundation of Hunan Province (2021JJ30505)
This publication has 33 references indexed in Scilit:
- Splenectomy Fails to Provide Long-Term Protection Against Ischemic StrokeAging and disease, 2018
- Research review on the pharmacological effects of astragalosideIVFundamental & Clinical Pharmacology, 2016
- Activation of the p62‐Keap1‐NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cellsHepatology, 2015
- p62 links autophagy and Nrf2 signalingFree Radical Biology and Medicine, 2015
- Sulforaphane preconditioning of the Nrf2/HO-1 defense pathway protects the cerebral vasculature against blood–brain barrier disruption and neurological deficits in strokeFree Radical Biology and Medicine, 2013
- Regulation of endoplasmic reticulum stress in rat cortex by p62/ZIP through the Keap1-Nrf2-ARE signalling pathway after transient focal cerebral ischaemiaBrain Injury, 2013
- Transcriptomic and proteomic profiling of KEAP1 disrupted and sulforaphane-treated human breast epithelial cells reveals common expression profilesBreast Cancer Research and Treatment, 2011
- Nrf2 regulates ferroportin 1-mediated iron efflux and counteracts lipopolysaccharide-induced ferroportin 1 mRNA suppression in macrophagesArchives of Biochemistry and Biophysics, 2011
- Behavioral and Histologic Neuroprotection of Aqueous Garlic Extract After Reversible Focal Cerebral IschemiaJournal of Medicinal Food, 2006
- Reversible middle cerebral artery occlusion without craniectomy in rats.Stroke, 1989